FDA Inspection 1047616 — American Red Cross Blood Services (The)
The FDA completed an inspection of American Red Cross Blood Services (The) on March 1, 2018 in Newark, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 1, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newark, CA (United States)